Search

Your search keyword '"Lassen, Jens Flensted"' showing total 670 results
Start Over Author "Lassen, Jens Flensted"
670 results on '"Lassen, Jens Flensted"'

102. 10-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments

Author

Kjøller-Hansen, Lars, Bligaard, Niels, Kelbæk, Henning, Christiansen, Evald Høj, Thuesen, Leif, Hansen, Peter R, Engstrøm, Thomas, Junker, Anders, Abildgaard, Ulrik, Lassen, Jens Flensted, Jensen, Jan S, Jeppesen, Jørgen L, and Galløe, Anders M

Subjects
cardiovascular system, cardiovascular diseases
Abstract

AIMS: To determine whether patients treated with drug-eluting stents in the proximal left anterior descending artery (LAD) carried a different long-term prognosis than patients treated in other coronary artery segments.METHODS AND RESULTS: 10-year clinical outcome expressed as all-cause mortality and major adverse cardiac events (MACE: cardiac death, acute myocardial infarction, or target vessel revascularization) was determined for 1,479 patients with a single non-left main coronary stenosis treated with a first-generation drug-eluting stent in the SORT OUT II trial. The outcome of patients treated with stents in the proximal LAD (n=365) was compared with that of patients treated in a non-proximal LAD segment (n=1,114). Follow-up was 99.3% complete. All-cause mortality was 24.9% in the proximal LAD group vs. 26.3% in the non-proximal LAD group (p=0.60). MACE occurred less frequently in the proximal LAD group 24.6% vs. 31.0% with hazard ratio 0.77 (95% confidence interval: 0.61-0.97, p=0.024). After multivariate analysis that included baseline characteristics that were unevenly distributed between the groups, the hazard ratio for MACE was 0.82 (95% confidence interval: 0.65-1.03, p=0.09).CONCLUSIONS: Patients treated with a drug-eluting stent in the proximal LAD have similar, if not better, long-term clinical outcome compared with patients stented in other coronary artery segments.

Published
2018

103. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (The MONAMI study)

Author

Terkelsen, Christian Juhl, Nørgaard, Bjarne Linde, Lassen, Jens Flensted, Poulsen, Steen Hvitfeldt, Gerdes, Jens Christian, Sloth, Erik, Gøtzsche, Liv Bjørn-Hansen, Rømer, Frode Kirketerp, Thuesen, Leif, Nielsen, Torsten Toftegaard, and Andersen, Henning Rud

Published
2006

108. Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI

Author

Laursen, Peter Nørkjær, primary, Holmvang, Lene, additional, Lønborg, Jacob, additional, Køber, Lars, additional, Høfsten, Dan E., additional, Helqvist, Steffen, additional, Clemmensen, Peter, additional, Kelbæk, Henning, additional, Jørgensen, Erik, additional, Lassen, Jens Flensted, additional, Pedersen, Frants, additional, Høi-Hansen, Thomas, additional, Raungaard, Bent, additional, Terkelsen, Christian Juhl, additional, Jensen, Lisette Okkels, additional, Sadjadieh, Golnaz, additional, and Engstrøm, Thomas, additional

Published
2019
Full Text
View/download PDF

109. Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction

Author

Nepper-Christensen, Lars, primary, Høfsten, Dan Eik, additional, Helqvist, Steffen, additional, Lassen, Jens Flensted, additional, Tilsted, Hans-Henrik, additional, Holmvang, Lene, additional, Pedersen, Frants, additional, Joshi, Francis, additional, Sørensen, Rikke, additional, Bang, Lia, additional, Bøtker, Hans Erik, additional, Terkelsen, Christian Juhl, additional, Maeng, Michael, additional, Jensen, Lisette Okkels, additional, Aarøe, Jens, additional, Kelbæk, Henning, additional, Køber, Lars, additional, Engstrøm, Thomas, additional, and Lønborg, Jacob, additional

Published
2019
Full Text
View/download PDF

110. Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial

Author

Jensen, Lisette Okkels, primary, Maeng, Michael, additional, Raungaard, Bent, additional, Engstrøm, Thomas, additional, Hansen, Henrik Steen, additional, Jensen, Svend Eggert, additional, Bøtker, Hans Erik, additional, Kahlert, Johnny, additional, Lassen, Jens Flensted, additional, and Christiansen, Evald Høj, additional

Published
2019
Full Text
View/download PDF

112. Joint consensus on the use of OCT in coronary bifurcation lesions by the European and Japanese bifurcation clubs

Author

Onuma, Yoshinobu, primary, Katagiri, Yuki, additional, Burzotta, Francesco, additional, Holm, Niels Ramsing, additional, Amabile, Nicolas, additional, Okamura, Takayuki, additional, Mintz, Gary S., additional, Darremont, Olivier, additional, Lassen, Jens Flensted, additional, Lefèvre, Thierry, additional, Louvard, Yves, additional, Stankovic, Goran, additional, and Serruys, Patrick W., additional

Published
2019
Full Text
View/download PDF

113. Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study

Author

Simonsen, Jo Krogsgaard, primary, Holck, Emil Nielsen, additional, Carrié, Didier, additional, Frey, Norbert, additional, Lutz, Matthias, additional, Weber-Albers, Joachim, additional, Dudek, Dariusz, additional, Chevalier, Bernard, additional, Daemen, Joost, additional, Dijkstra, Jouke, additional, Fox Maule, Camilla, additional, Neghabat, Omeed, additional, Lassen, Jens Flensted, additional, Anderson, Jeffrey, additional, Christiansen, Evald Høj, additional, Abizaid, Alexandre, additional, and Holm, Niels Ramsing, additional

Published
2019
Full Text
View/download PDF

114. Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study

Author

van Zandvoort, Laurens J.C., primary, Dudek, Dariusz, additional, Weber-Albers, Joachim, additional, Abizaid, Alexandre, additional, Christiansen, Evald Høj, additional, Muller, David W.M., additional, Kochman, Janusz, additional, Kołtowski, Łukasz, additional, Lassen, Jens Flensted, additional, Wojdyla, Roman, additional, Wykrzykowska, Joanna J., additional, Onuma, Yoshinobu, additional, and Daemen, Joost, additional

Published
2018
Full Text
View/download PDF

115. Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study

Author

Laursen, Peter Nørkjær, primary, Holmvang, Lene, additional, Lønborg, Jacob, additional, Køber, Lars, additional, Høfsten, Dan E., additional, Helqvist, Steffen, additional, Clemmensen, Peter, additional, Kelbæk, Henning, additional, Jørgensen, Erik, additional, Lassen, Jens Flensted, additional, Pedersen, Frants, additional, Høi-Hansen, Thomas, additional, Therkelsen, Christian Juhl, additional, Tilsted, Hans-Henrik, additional, Jensen, Lisette Okkels, additional, Nepper-Christensen, Lars, additional, Sadjadieh, Golnaz, additional, and Engstrøm, Thomas, additional

Published
2018
Full Text
View/download PDF

116. Ten-year All-cause Mortality after Simple versus Complex Stenting of Coronary Artery Bifurcation Lesions in the Randomized Nordic Bifurcation Study

Author

Steigen, Terje, Holm, Niels, Kumsars, Indulis, Niemela, Matti, James, Stefan, Erglis, Andrejs, Kervinen, Kari, Jensen, Jan Skov, Galloe, Anders Michael, Wiseth, Rune, Gunnes, Paul, Meyerdierks, Oliver, Rotevatn, Svein, Vikman, Saila, Maeng, Michael, Ravkilde, Jan, Ylitalo, Antti, Helqvist, Steffen, Sjogren, Iwar, Jensen, Lisette Okkels, Laine, Mika, Hartikainen, Juha, Airaksinen, Juhani, Lassen, Jens Flensted, Thuesen, Leif, and Christiansen, Evald

Published
2016

118. TCT-10 Physiological testing of coronary artery stenosis by computation of invasive coronary angiography. The wire-free functional imaging (WIFI-II) study

Author

Westra, Jelmer Sybren, Tu, Shengxian, Nissen, Louise, Winther, Simon, Vestergaard, Mai-Britt, Andersen, Birgitte Krogsgaard, Holck, Emil, Maule, Camilla Fox, Frost, Lars, Andreasen, Lene Nyhus, Simonsen, Jo, Zhang, Yimin, Kristensen, Steen Dalby, Maeng, Michael, Kaltoft, Anne, Terkelsen, Christian, Krusell, Lars Romer, Jakobsen, Lars, Reiber, Johan, Lassen, Jens Flensted, Bottcher, Morten, Botker, Hans Erik, Christiansen, Evald, and Holm, Niels

Subjects
medicine.medical_specialty, business.industry, 030229 sport sciences, Coronary stenosis, 030204 cardiovascular system & hematology, Functional imaging, Invasive coronary angiography, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Cardiology, Medicine, Cardiology and Cardiovascular Medicine, business
Published
2016

120. Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis

Author

Collet, Jean-Philippe, primary, Kerneis, Mathieu, additional, Lattuca, Benoit, additional, Yan, Yan, additional, Cayla, Guillaume, additional, Silvain, Johanne, additional, Lapostolle, Frédéric, additional, Ecollan, Patrick, additional, Diallo, Abdourahmane, additional, Vicaut, Eric, additional, Hamm, Christian W., additional, Van ‘t Hof, Arnoud W., additional, Montalescot, Gilles, additional, Lassen, Jens Flensted, additional, Bolognese, Leonardo, additional, Cantor, Warren J., additional, Cequier, Àngel, additional, Chettibi, Mohamed, additional, Goodman, Shaun G., additional, Hammett, Christopher J., additional, Huber, Kurt, additional, Janzon, Magnus, additional, Merkely, Béla, additional, Storey, Robert F., additional, ten Berg, Jurrien M., additional, Zeymer, Uwe, additional, Licour, Muriel, additional, and Tsatsaris, Anne, additional

Published
2018
Full Text
View/download PDF

121. Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments

Author

Kjøller-Hansen, Lars, primary, Bligaard, Niels, additional, Kelbæk, Henning, additional, Christiansen, Evald Høj, additional, Thuesen, Leif, additional, Hansen, Peter R., additional, Engstrøm, Thomas, additional, Junker, Anders, additional, Abildgaard, Ulrik, additional, Lassen, Jens Flensted, additional, Jensen, Jan S., additional, Jeppesen, Jørgen L., additional, and Galløe, Anders M., additional

Published
2018
Full Text
View/download PDF

122. Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club

Author

Burzotta, Francesco, primary, Lassen, Jens Flensted, additional, Banning, Adrian P., additional, Lefèvre, Thierry, additional, Hildick-Smith, David, additional, Chieffo, Alaide, additional, Darremont, Olivier, additional, Pan, Manuel, additional, Chatzizisis, Yiannis S., additional, Albiero, Remo, additional, Louvard, Yves, additional, and Stankovic, Goran, additional

Published
2018
Full Text
View/download PDF

123. Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial

Author

Engstrøm, Thomas, primary, Nepper-Christensen, Lars, additional, Helqvist, Steffen, additional, Kløvgaard, Lene, additional, Holmvang, Lene, additional, Jørgensen, Erik, additional, Pedersen, Frants, additional, Saunamaki, Kari, additional, Tilsted, Hans-Henrik, additional, Steensberg, Adam, additional, Fabricius, Søren, additional, Mouritzen, Ulrik, additional, Vejlstrup, Niels, additional, Ahtarovski, Kiril A, additional, Göransson, Christoffer, additional, Bertelsen, Litten, additional, Kyhl, Kasper, additional, Olivecrona, Göran, additional, Kelbæk, Henning, additional, Lassen, Jens Flensted, additional, Køber, Lars, additional, and Lønborg, Jacob, additional

Published
2018
Full Text
View/download PDF

124. CRT-600.05 Intravascular Ultrasound Findings of the Fantom Bioresorbable Scaffold at 6 and 9 Months Follow-up: Results from the Multicenter FANTOM II Study

Author

Daemen, Joost, primary, van Zandvoort, Laurens, additional, Dudek, Dariusz, additional, Weber - Alders, Joachim, additional, Christiansen, Evald, additional, Muller, David, additional, Kochman, Janusz, additional, Lassen, Jens Flensted, additional, Wojdyla, Roman, additional, Wykrzykowska, Joanna, additional, and Abizaid, Alexandre, additional

Published
2018
Full Text
View/download PDF

126. P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction

Author

Silvain, Johanne, Storey, Robert, Cayla, Guillaume, Esteve, Jean-Baptiste, Dillinger, Jean-Guillaume, Rousseau, Hélène, Tsatsaris, Anne, Baradat, Caroline, Salhi, Néjoua, Hamm, Christian, Lapostolle, Frédéric, Lassen, Jens Flensted, Collet, Jean-Philippe, Ten Berg, Jurriën, van't Hof, Arnoud, Montalescot, Gilles, Institut de cardiologie [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN), Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), University of Sheffield [Sheffield], Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Université de Montpellier (UM), Centre Hospitalier Universitaire de La Réunion (CHU La Réunion), Hôpital Lariboisière, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Biomarqueurs CArdioNeuroVASCulaires (BioCANVAS), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), AstraZeneca, AstraZeneca [Cambridge, UK], Hôpital Avicenne [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Aarhus University Hospital, St. Antonius Hospital [Nieuwegein], Isala Clinics, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Pitié-Salpêtrière [APHP], Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [APHP], Centre Hospitalier Régional Universitaire de Nîmes (CHRU Nîmes), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Lariboisière-Université Paris Diderot - Paris 7 (UPD7), Hôpital avicenne, and Université Paris 13 (UP13)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Avicenne

Subjects
STEMI, platelet reactivity, Ticagrelor, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, PCI, morphine, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology
Abstract

International audience; PRIVATE-ATLANTIC (P2Y12 Receptor Inhibition with VASP Testing using Elisa kit during the ATLANTIC study) is a pre-specified substudy of the randomised, double-blind ATLANTIC trial in patients with ST-segment elevation myocardial infarction, designed to help interpret the main trial results. The primary objective of ATLANTIC was to assess coronary reperfusion prior to percutaneous coronary intervention (PCI) with pre- vs in-hospital ticagrelor 180 mg loading dose (LD). PRIVATE-ATLANTIC assessed platelet inhibition in 37 patients by measurement of vasodilator-associated stimulated phosphoprotein (VASP) platelet reactivity index (PRI) and VerifyNow platelet reactivity units (PRU) before angiogram (T1), immediately after PCI (T2), 1 (T3), and 6 (T4) hours (h) after PCI, and before next study drug administration (T5). The median time difference between the two ticagrelor LD was 41 minutes. Platelet reactivity was unaffected at T1 when measured by VASP-PRI (89.8 vs 93.9 % for pre- and in-hospital ticagrelor, respectively; p = 0.18) or PRU (239 vs 241; p = 0.82). Numerical differences were apparent at T2 and maximal at T3. Morphine administration significantly delayed onset of platelet inhibition at T3 (VASP-PRI 78.2 vs 23.4 % without morphine; p = 0.0116) and T4 (33.1 vs 11.0 %; p = 0.0057). In conclusion, platelet inhibition in ATLANTIC was unaffected by pre-hospital ticagrelor administration at the time of initial angiogram due to the short transfer delay. The maximum difference in platelet inhibition was detected 1 h after PCI (T3). Morphine administration was associated with delayed onset of action of ticagrelor and appeared more important than timing of ticagrelor administration.TRIAL REGISTRATION:ClinicalTrials.gov NCT01347580.

Published
2016

127. Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents:5-Year Results From SORT OUT IV

Author

Jensen, Lisette Okkels, Thayssen, Per, Christiansen, Evald Høj, Maeng, Michael, Ravkilde, Jan, Hansen, Knud Nørregaard, Hansen, Henrik Steen, Krusell, Lars, Kaltoft, Anne, Tilsted, Hans Henrik, Berencsi, Klara, Junker, Anders, and Lassen, Jens Flensted

Subjects
percutaneous coronary intervention, outcome, cardiovascular diseases, very late definite stent thrombosis, drug-eluting stent(s)
Abstract

BACKGROUND: Long-term safety and efficacy for everolimus-eluting stents (EES) versus those of sirolimus-eluting stents (SES) are unknown.OBJECTIVES: This study compared 5-year outcomes for EES with those for SES from the SORT OUT IV (Scandinavian Organization for Randomized Trials with Clinical Outcome) trial.METHODS: Five-year follow-up was completed for 2,771 patients (99.9%). Primary endpoint was a composite of major adverse cardiac events (MACE), including cardiac death, myocardial infarction (MI), target vessel revascularization (TVR), and definite stent thrombosis.RESULTS: At 5-years, MACE occurred in 14.0% and 17.4% in the EES and SES groups, respectively (hazard ratio [HR]: 0.80, 95% confidence interval [CI]: 0.66 to 0.97; p = 0.02). The MACE rate did not differ significantly within the first year (HR: 0.96, 95% CI: 0.71 to 1.19; p = 0.79), but from years 1 through 5, the MACE rate was lower with EES (HR: 0.71, 95% CI: 0.55 to 0.90; p = 0.006; p interaction = 0.12). Definite stent thrombosis was lower with EES (0.4%) than with SES (2.0%; HR: 0.18, 95% CI: 0.07 to 0.46), with a lower risk of very late definite stent thrombosis in the EES group (0.2% vs. 1.4%, respectively; HR: 0.16, 95% CI: 0.05 to 0.53). When censoring the patients at the time of stent thrombosis, we found no significant differences between the 2 stent groups for MACE rates (HR: 0.89, 95% CI: 0.73 to 1.08; p = 0.23), target lesion revascularization (HR: 0.90, 95% CI: 0.64 to 1.27; p = 0.55), and MI (HR: 0.93, 95% CI: 0.64 to 1.36; p = 0.72).CONCLUSIONS: At 5-year follow-up, MACE rate was significantly lower with EES- than with SES-treated patients, due largely due to a lower risk of very late definite stent thrombosis. (Randomized Clinical Comparison of the Xience V and the Cypher Coronary Stents in Non-selected Patients With Coronary Heart Disease [SORT OUT IV]; NCT00552877).

Published
2016

128. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis

Author

Ten Berg, Jurriën M, Zeymer, Uwe, Goodman, Shaun G, Van 'T Hof, Arnoud W, Lassen, Jens Flensted, Hamm, Christian W, Collet, Jean-Philippe, Salhi, Néjoua, Huber, Kurt, Storey, Robert F, Tsatsaris, Anne, Merkely, Béla, Cantor, Warren J, Lapostolle, Frédéric, Licour, Muriel, Hammett, Christopher J, Montalescot, Gilles, Cequier, Angel, Bolognese, Leonardo, Silvain, Johanne, Chettibi, Mohamed, Vicaut, Eric, and Janzon, Magnus

Subjects
610 Medicine & health
Abstract

OBJECTIVES The aim of this landmark exploratory analysis, ATLANTIC-H(24), was to evaluate the effects of pre-hospital ticagrelor during the first 24 h after primary percutaneous coronary intervention (PCI) in the ATLANTIC (Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial infarction to open the Coronary artery) study. BACKGROUND The ATLANTIC trial in patients with ongoing ST-segment elevation myocardial infarction showed that pre-hospital ticagrelor was safe but did not improve pre-PCI coronary reperfusion compared with in-hospital ticagrelor. We hypothesized that the effect of pre-hospital ticagrelor may not have manifested until after PCI due to the rapid transfer time (31 min). METHODS The ATLANTIC-H(24) analysis included 1,629 patients who underwent PCI, evaluating platelet reactivity, Thrombolysis In Myocardial Infarction flow grade 3, ≥ 70% ST-segment elevation resolution, and clinical endpoints over the first 24 h. RESULTS Following PCI, largest between-group differences in platelet reactivity occurred at 1 to 6 h; coronary reperfusion rates numerically favored pre-hospital ticagrelor, and the degree of ST-segment elevation resolution was significantly greater in the pre-hospital group (median, 75.0% vs. 71.4%; p = 0.049). At 24 h, the composite ischemic endpoint was lower with pre-hospital ticagrelor (10.4% vs. 13.7%; p = 0.039), as were individual endpoints of definite stent thrombosis (p = 0.0078) and myocardial infarction (p = 0.031). All endpoints except death (1.1% vs. 0.2%; p = 0.048) favored pre-hospital ticagrelor, with no differences in bleeding events. CONCLUSIONS The effects of pre-hospital ticagrelor became apparent after PCI, with numerical differences in platelet reactivity and immediate post-PCI reperfusion, associated with reductions in ischemic endpoints, over the first 24 h, whereas there was a small excess of mortality. (Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial infarction to open the Coronary artery [ATLANTIC, NCT01347580]).

Published
2016
Full Text
View/download PDF

129. Renal Sympathetic Denervation in Treatment Resistant Essential Hypertension.:A Sham-Controlled, Double-blinded Randomized Trial (ReSET trial)

Author

Mathiassen, Ole, Bech, Jesper N., Buus, Niels Henrik, Christensen, Kent Lodberg, Vase, Henrik, Bertelsen, Jannik, Rickers, Hans, Kampmann, Ulla, Pedersen, Morten Engholm, L. Pedersen, Ole, Peters, Christian Daugaard, Poulsen, Per Løgstrup, Lassen, Jens Flensted, Hansen, Klavs Würgler, Bøtker, Hans Erik, Schroeder, Pauline, Pedersen, Erling Bjerregaard, and Kaltoft, Anne Kjer

Published
2015

130. Association between socioeconomic factors and ICD implantation in a publicly financed health care system: a Danish nationwide study

Author

Winther-Jensen, Matilde, primary, Hassager, Christian, additional, Lassen, Jens Flensted, additional, Køber, Lars, additional, Torp-Pedersen, Christian, additional, Hansen, Steen Møller, additional, Lippert, Freddy, additional, Christensen, Erika Frischknecht, additional, Kragholm, Kristian, additional, and Kjaergaard, Jesper, additional

Published
2017
Full Text
View/download PDF

131. Distance to invasive heart centre, performance of acute coronary angiography, and angioplasty and associated outcome in out-of-hospital cardiac arrest: a nationwide study

Author

Tranberg, Tinne, primary, Lippert, Freddy K., additional, Christensen, Erika F., additional, Stengaard, Carsten, additional, Hjort, Jakob, additional, Lassen, Jens Flensted, additional, Petersen, Frants, additional, Jensen, Jan Skov, additional, Bäck, Caroline, additional, Jensen, Lisette Okkels, additional, Ravkilde, Jan, additional, Bøtker, Hans Erik, additional, and Terkelsen, Christian Juhl, additional

Published
2017
Full Text
View/download PDF

132. Meeting abstracts from the first European Emergency Medical Services congress (EMS2016)

Author

White, Alexander, primary, Ng, Han Xian, additional, Ng, Wai Yee, additional, Ng, Eileen Kai Xin, additional, Fook-Chong, Stephanie, additional, Kua, Phek Hui Jade, additional, Ong, Marcus Eng Hock, additional, Steensberg, Alvilda Thougaard, additional, Andersen, Lars Bredevang, additional, Eriksen, Mette Mølby, additional, Hendriksen, Ole Mazur, additional, Thougaard, Thomas, additional, Claesson, Andreas, additional, Lennartsson, J., additional, Svensson, L., additional, Ringh, M., additional, Hollenberg, J., additional, Nordberg, P., additional, Rosenqvist, M., additional, Djarv, T., additional, Österberg, S., additional, Fredman, D., additional, Ban, Y., additional, Löwe, Anne-Sophie, additional, Nielsen, Jacob, additional, Zimling, Martin, additional, Schmidt, Jakob, additional, Lippert, Freddy, additional, Ersbøll, Annette K., additional, Møller, Thea Palsgaard, additional, Jørgensen, Mikkel D., additional, Hamilton, Annika, additional, Steinmetz, Jacob, additional, Wissenberg, Mads, additional, Torp-Pedersen, Christian, additional, Hove, Lars, additional, Lohse, Nicolai, additional, Thorsager, Bodil, additional, Bonde, Hanne, additional, Rasmussen, Maria Birkvad, additional, Østergaard, Doris, additional, Hansen, Camilla Schade, additional, Brabrand, Mikkel, additional, Lassen, Annmarie, additional, Kjer, Cilia, additional, Holgersen, Mathias, additional, Viggers, Sandra, additional, Pedersen, Claus Kjær, additional, Bøtker, Morten Thingemann, additional, Riddervold, Ingunn Skogstad, additional, Terkelsen, Christian Juhl, additional, Nystøyl, Dag S., additional, Hunskaar, S., additional, Zakariassen, E., additional, Fredman, David, additional, Svensson, Leif, additional, Ban, Yifang, additional, Jonsson, Martin, additional, Hollenberg, Jacob, additional, Nordberg, Per, additional, Ringh, Mattias, additional, Rosenqvist, Mårten, additional, Lundén, Margareta, additional, Haas, Jan, additional, Ribeiro, Filipe, additional, Newton, Mark, additional, Freitas, Paulo, additional, Rocha, Dario, additional, Leal, Emilio, additional, Santos, Nuno, additional, Cortez, Tania, additional, Allmark, Stephanie, additional, Marsden, Janet, additional, Linderoth, Gitte, additional, Thomas, Grethe, additional, Nielsen, Anne Møller, additional, Øllgaard, Gertrud, additional, Inaba, Hideo, additional, Yamashita, Akira, additional, Maeda, Testuo, additional, Bakke, Håkon Kvåle, additional, Steinvik, Tine, additional, Angell, Johan, additional, Wisborg, Torben, additional, Ruud, Håkon, additional, Haug, Ingunn Anda, additional, Birkenes, Tonje S., additional, Myklebust, Helge, additional, Kramer-Johansen, Jo, additional, Funder, Kamilia S., additional, Rasmussen, Lars S., additional, Hesselfeldt, Rasmus, additional, Siersma, Volkert, additional, Sonne, Asger, additional, Wulffeld, Sandra, additional, Funde, amilia S., additional, Pedersen, Frants, additional, Hendriksen, Ole M., additional, Lippert, Freddy K., additional, Sol-A, Kim, additional, Shin, Sand Do, additional, Lee, Kyungwon, additional, Lee, Eui Jung, additional, Ro, Young Sun, additional, Hong, Ki Jeong, additional, Kim, Yu Jin, additional, Jeong, Joo, additional, Ho, Park Jeong, additional, Binderup, Lars Grassmé, additional, Mikkelsen, Søren, additional, de Muckadell, Caroline Schaffalitzky, additional, Lossius, Hans Morten, additional, Toft, Palle, additional, Lassen, Annmarie Touborg, additional, Thompson, Lee, additional, Hill, Michael, additional, Hov, Maren Ranhoff, additional, Lindner, Thomas, additional, Franer, Eirik, additional, Monstad, Andreas, additional, Lund, Christian G., additional, Betzer, Martin, additional, Lyngby, Rasmus Malmberg, additional, Jousi, Milla, additional, Nurmi, Jouni, additional, Kruse, Nanna, additional, Barfod, Charlotte, additional, Raaber, Nikolaj, additional, Bøtker, Morten T., additional, Seidenfaden, Sophie-Charlott, additional, Riddervold, Ingunn S., additional, Simpson, Paul, additional, Thyer, Liz, additional, van Nugteren, Ben, additional, Kirkegaard, Hans, additional, Juul, Niels, additional, Zwisler, T., additional, Rønnov, Camilla, additional, Mieritz, Hanne B., additional, Jørgensen, Gitte, additional, Ångerman-Haasmaa, Susanne, additional, Länkimäki, Sami, additional, Viereck, Søren, additional, Rothman, Josephine Philip, additional, Folke, Fredrik, additional, Filipescu, Teodora, additional, Gray, Alasdair, additional, Williams, Teresa A, additional, Ho, Kwok M., additional, Tohira, Hideo, additional, Fatovich, Daniel, additional, Brink, Deon, additional, Bailey, Paul, additional, Perkins, Gavin D., additional, Finn, Judith, additional, Ersbøll, Annette Kjær, additional, Kjærulff, Thora Majlund, additional, Tolstrup, Janne Shurmann, additional, Andersen, Jon Trærup, additional, Overton, Jerry, additional, Jensen, Theo Walther, additional, Roland, Jens, additional, Lassen, Jens Flensted, additional, Puolakka, Tuukka, additional, Puolakka, Jyrki, additional, Hallikainen, Juhana, additional, Rantanen, Kirsi, additional, and Kuisma, Markku, additional

Published
2017
Full Text
View/download PDF

133. TCT-29 Performance and healing patterns after implantation of a novel sirolimus eluting bioresorbable scaffold. Six-month follow-up by optical coherence tomography in the FANTOM II study

Author

Simonsen, Jo, primary, Holck, Emil, additional, Carrié, Didier, additional, Frey, Norbert, additional, Lutz, Matthias, additional, Weber-Albers, Joachim, additional, Dudek, Dariusz, additional, Chevalier, Bernard, additional, Dijkstra, Jouke, additional, Lassen, Jens Flensted, additional, Anderson, Jeffrey, additional, Christiansen, Evald, additional, Abizaid, Alexandre, additional, and Holm, Niels, additional

Published
2016
Full Text
View/download PDF

134. TCT-451 Two-year outcomes after revascularization with a biodegradable polymer ultra-thin strut sirolimus eluting stent and a biodegradable polymer biolimus-eluting stent. From the SORT OUT VII trial

Author

Jensen, Lisette Okkels, primary, Maeng, Michael, additional, Raungaard, Bent, additional, Hansen, Knud Noerregaard, additional, Kahlert, Johnny, additional, Jensen, Svend Eggert, additional, Bøtker, Hans Erik, additional, Hansen, Henrik, additional, Lassen, Jens Flensted, additional, and Christiansen, Evald, additional

Published
2016
Full Text
View/download PDF

135. TCT-321 Definite and probable stent thrombosis after revascularization with drug-eluting stents with a biodegradable polymer. From the randomized SORT OUT VII Trial

Author

Jensen, Lisette Okkels, primary, Maeng, Michael, additional, Raungaard, Bent, additional, Hansen, Knud Noerregaard, additional, Kahlert, Johnny, additional, Jensen, Svend Eggert, additional, Bøtker, Hans Erik, additional, Hansen, Henrik, additional, Lassen, Jens Flensted, additional, and Christiansen, Evald, additional

Published
2016
Full Text
View/download PDF

136. TCT-318 Ten-year All-cause Mortality after Simple versus Complex Stenting of Coronary Artery Bifurcation Lesions in the Randomized Nordic Bifurcation Study

Author

Steigen, Terje, primary, Holm, Niels, additional, Kumsars, Indulis, additional, Niemela, Matti, additional, James, Stefan, additional, Erglis, Andrejs, additional, Kervinen, Kari, additional, Jensen, Jan Skov, additional, Galloe, Anders Michael, additional, Wiseth, Rune, additional, Gunnes, Paul, additional, Meyerdierks, Oliver, additional, Rotevatn, Svein, additional, Vikman, Saila, additional, Maeng, Michael, additional, Ravkilde, Jan, additional, Ylitalo, Antti, additional, Helqvist, Steffen, additional, Sjogren, Iwar, additional, Jensen, Lisette Okkels, additional, Laine, Mika, additional, Hartikainen, Juha, additional, Airaksinen, Juhani, additional, Lassen, Jens Flensted, additional, Thuesen, Leif, additional, and Christiansen, Evald, additional

Published
2016
Full Text
View/download PDF

137. Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction

Author

Nepper-Christensen, Lars, Høfsten, Dan Eik, Helqvist, Steffen, Lassen, Jens Flensted, Tilsted, Hans-Henrik, Holmvang, Lene, Pedersen, Frants, Joshi, Francis, Sørensen, Rikke, Bang, Lia, Bøtker, Hans Erik, Terkelsen, Christian Juhl, Maeng, Michael, Jensen, Lisette Okkels, Aarøe, Jens, Kelbæk, Henning, Køber, Lars, Engstrøm, Thomas, and Lønborg, Jacob

Abstract

ObjectiveThe Third Danish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction – Ischaemic Postconditioning (DANAMI-3-iPOST) did not show improved clinical outcome in patients with ST-segment elevation myocardial infarction (STEMI) treated with ischaemic postconditioning. However, the use of thrombectomy was frequent and thrombectomy may in itself diminish the effect of ischaemic postconditioning. We evaluated the effect of ischaemic postconditioning in patients included in DANAMI-3-iPOST stratified by the use of thrombectomy.MethodsPatients with STEMI were randomised to conventional primary percutaneous coronary intervention (PCI) or ischaemic postconditioning plus primary PCI. The primary endpoint was a combination of all-cause mortality and hospitalisation for heart failure.ResultsFrom March 2011 until February 2014, 1234 patients were included with a median follow-up period of 35 (interquartile range 28 to 42) months. There was a significant interaction between ischaemic postconditioning and thrombectomy on the primary endpoint (p=0.004). In patients not treated with thrombectomy (n=520), the primary endpoint occurred in 33 patients (10%) who underwent ischaemic postconditioning (n=326) and in 35 patients (18%) who underwent conventional treatment (n=194) (adjusted hazard ratio (HR) 0.55 (95%confidence interval (CI) 0.34 to 0.89), p=0.016). In patients treated with thrombectomy (n=714), there was no significant difference between patients treated with ischaemic postconditioning (n=291) and conventional PCI (n=423) on the primary endpoint (adjusted HR 1.18 (95% CI 0.62 to 2.28), p=0.62).ConclusionsIn this post-hoc study of DANAMI-3-iPOST, ischaemic postconditioning, in addition to primary PCI, was associated with reduced risk of all-cause mortality and hospitalisation for heart failure in patients with STEMI not treated with thrombectomy.Trial registration numberNCT01435408.

Published
2020
Full Text
View/download PDF

138. Pre‐hospital administration of ticagrelor in diabetic patients with ST‐elevation myocardial infarction undergoing primary angioplasty: A sub‐analysis of the ATLANTIC trial.

Author

Fabris, Enrico, van't Hof, Arnoud, Hamm, Christian W., Lapostolle, Frédéric, Lassen, Jens Flensted, Goodman, Shaun G., ten Berg, Jurriën M., Bolognese, Leonardo, Cequier, Angel, Chettibi, Mohamed, Hammett, Christopher J., Huber, Kurt, Janzon, Magnus, Merkely, Béla, Storey, Robert F., Zeymer, Uwe, Cantor, Warren J., Kerneis, Mathieu, Diallo, Abdourahmane, and Vicaut, Eric

Published
2019
Full Text
View/download PDF

139. Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine.

Author

Lapostolle, Frédéric, van't Hof, Arnoud W., Hamm, Christian W., Stibbe, Olivier, Ecollan, Patrick, Collet, Jean-Philippe, Silvain, Johanne, Lassen, Jens Flensted, Heutz, Wim M. J. M., Bolognese, Leonardo, Cantor, Warren J., Cequier, Angel, Chettibi, Mohamed, Goodman, Shaun G., Hammett, Christopher J., Huber, Kurt, Janzon, Magnus, Merkely, Béla, Storey, Robert F., and ten Berg, Jur

Subjects
CHEST pain diagnosis, ADENOSINE triphosphate, AGE distribution, CARDIOVASCULAR diseases risk factors, CHEST pain, DRUG interactions, ELECTROCARDIOGRAPHY, GLYCOPROTEINS, HEMORRHAGE, MORPHINE, MYOCARDIAL infarction, MYOCARDIAL revascularization, PREANESTHETIC medication, SEX distribution, SURGICAL stents, PAIN management, TREATMENT effectiveness, RETROSPECTIVE studies, PERCUTANEOUS coronary intervention, CHEMICAL inhibitors
Abstract

Background: Morphine adversely impacts the action of oral adenosine diphosphate (ADP)-receptor blockers in ST-segment elevation myocardial infarction (STEMI) patients, and is possibly associated with differing patient characteristics. This retrospective analysis investigated whether interaction between morphine use and pre-percutaneous coronary intervention (pre-PCI) ST-segment elevation resolution in STEMI patients in the ATLANTIC study was associated with differences in patient characteristics and management.Methods: ATLANTIC was an international, multicenter, randomized study of treatment in the acute ambulance/hospital setting where STEMI patients received ticagrelor 180 mg ± morphine. Patient characteristics, cardiovascular history, risk factors, management, and outcomes were recorded.Results: Opioids (97.6% morphine) were used in 921 out of 1862 patients (49.5%). There were no significant differences in age, sex or cardiovascular history, but more morphine-treated patients had anterior myocardial infarction and left-main disease. Time from chest pain to electrocardiogram and ticagrelor loading was shorter with morphine (both p = 0.01) but not total ischemic time. Morphine-treated patients more frequently received glycoprotein IIb/IIIa inhibitors (p = 0.002), thromboaspiration and stent implantation (both p < 0.001). No significant difference between the two groups was found regarding pre-PCI ≥ 70% ST-segment elevation resolution, death, myocardial infarction, stroke, urgent revascularization and definitive acute stent thrombosis. More morphine-treated patients had an absence of pre-PCI Thrombolysis in Myocardial Infarction (TIMI) 3 flow (85.8% vs. 79.7%; p = 0.001) and more had TIMI major bleeding (1.1% vs. 0.1%; p = 0.02).Conclusions: Morphine-treatment was associated with increased GP IIb/IIIa inhibitor use, less pre-PCI TIMI 3 flow, and more bleeding. Judicious morphine use is advised with non-opioid analgesics preferred for non-severe acute pain.Trial Registration: clinicaltrials.gov identifier: NCT01347580. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

140. In memoriam Alfonso Medina Fernandez-Aceituno, MD, 1946-2017. Goodbye to a friend and to a 1,1,1 cardiologist

Author

Louvard Yves, Ferenc Miroslaw, Lassen Jens Flensted, P Banning Adrian, Burzotta Francesco, S Chatzizisis Yiannis, Hildick-Smith David, Lefèvre Thierry, Chieffo Alaide, Stankovic Goran, Darremont Olivier, and Pan Manuel

Subjects
03 medical and health sciences, 0302 clinical medicine, business.industry, Medicine, 030229 sport sciences, 030204 cardiovascular system & hematology, Cardiology and Cardiovascular Medicine, business, Humanities
Published
2017

141. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients:the randomized diabetes and drug-eluting stent (DiabeDES) IV intravascular ultrasound trial

Author

Antonsen, Lisbeth, Maeng, Michael, Thayssen, Per, Christiansen, Evald Høj, Hansen, Knud Nørregaard, Kaltoft, Anne, Hansen, Henrik Steen, Thuesen, Leif, Lassen, Jens Flensted, and Jensen, Lisette Okkels

Abstract

OBJECTIVE: To evaluate the effects of the everolimus-eluting Xience™/Promus™ stent (EES) and the sirolimus-eluting Cypher™ stent (SES) on intimal hyperplasia (IH) in diabetic patients.BACKGROUND: Patients with diabetes mellitus have increased risk of in-stent restenosis after coronary stent implantation due to intimal hyperplasia (IH).METHODS: In a sub study of the Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated with Percutaneous Coronary Intervention (SORT OUT IV trial), serial intravascular ultrasound (IVUS) 10-month follow-up data were available in 88 patients, including 48 EES and 40 SES treated patients. IVUS endpoints included IH volume, in-stent % volume obstruction and changes in external elastic membrane (EEM) volume.RESULTS: Compared with the SES group, IH volume was increased in the EES group [median (interquartile range): 2.8 mm(3) (0.0-12.6) vs. 0.0 mm(3) (0.0-1.1), P = 0.001]. In-stent % volume obstruction was increased in EES compared to SES [median (interquartile range): 1.6% (0.0-8.2) vs. 0.0% (0.0-1.0), P = 0.001]. Peri-stent external elastic membrane (EEM) volume: (post procedure vs. follow-up EES [300 mm(3) (219-491) vs. 307 mm(3) (223-482), P = 0.73] and SES [316 mm(3) (235-399) vs. 323 mm(3) (246-404), P = 0.05]) and peri-stent plaque volume: EES [163 mm(3) (103-273) vs. 184 mm(3) (115-291), P = 0.18] and SES [186 mm(3) (139-248) vs. 175 mm(3) (153-243), P = 0.26]) were unchanged in both groups. In the proximal reference segment a significant increase in plaque area was seen in the EES group only, without vascular remodeling.CONCLUSION: In diabetic patients, EES stent implantation was associated with increased IH volume obstruction without involvement of vascular remodeling.

Published
2014

146. Quality of Danish CPR courses for laypersons

Author

Jensen, Theo Walther, primary, Møller, Thea Palsgaard, additional, Viereck, Søren, additional, Roland, Jens, additional, Pedersen, Thomas Egesborg, additional, Ersbøll, Anette, additional, Folke, Fredrik, additional, Lassen, Jens Flensted, additional, Østergaard, Doris, additional, and Lippert, Freddy K., additional

Published
2016
Full Text
View/download PDF

147. Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention

Author

Jensen, Lisette Okkels, primary, Thayssen, Per, additional, Maeng, Michael, additional, Ravkilde, Jan, additional, Krusell, Lars Romer, additional, Raungaard, Bent, additional, Junker, Anders, additional, Terkelsen, Christian Juhl, additional, Veien, Karsten Tange, additional, Villadsen, Anton Boel, additional, Kaltoft, Anne, additional, Tilsted, Hans-Henrik, additional, Hansen, Knud Nørregaard, additional, Aaroe, Jens, additional, Kristensen, Steen Dalby, additional, Hansen, Henrik Steen, additional, Jensen, Svend Eggert, additional, Madsen, Morten, additional, Bøtker, Hans Erik, additional, Berencsi, Klára, additional, Lassen, Jens Flensted, additional, and Christiansen, Evald Høj, additional

Published
2016
Full Text
View/download PDF

148. Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study

Author

Behan, Miles W., primary, Holm, Niels R., additional, de Belder, Adam J., additional, Cockburn, James, additional, Erglis, Andrejs, additional, Curzen, Nicholas P., additional, Niemelä, Matti, additional, Oldroyd, Keith G., additional, Kervinen, Kari, additional, Kumsars, Indulis, additional, Gunnes, Paal, additional, Stables, Rodney H., additional, Maeng, Michael, additional, Ravkilde, Jan, additional, Jensen, Jan Skov, additional, Christiansen, Evald H., additional, Cooter, Nina, additional, Steigen, Terje K., additional, Vikman, Saila, additional, Thuesen, Leif, additional, Lassen, Jens Flensted, additional, and Hildick-Smith, David, additional

Published
2016
Full Text
View/download PDF

149. INTERACTION BETWEEN MORPHINE AND TICAGRELOR IN THE ATLANTIC STUDY

Author

Lapostolle, Frédéric, primary, van ‘t Hof, Arnoud W., additional, Hamm, Christian W., additional, Lassen, Jens Flensted, additional, Stibbe, Olivier, additional, Ecollan, Patrick, additional, Heutz, Wim M.J.M, additional, Licour, Muriel, additional, Tsatsaris, Anne, additional, and Montalescot, Gilles, additional

Published
2016
Full Text
View/download PDF

150. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction

Author

Montalescot, Gilles, primary, van ’t Hof, Arnoud W., additional, Bolognese, Leonardo, additional, Cantor, Warren J., additional, Cequier, Angel, additional, Chettibi, Mohamed, additional, Collet, Jean-Philippe, additional, Goodman, Shaun G., additional, Hammett, Christopher J., additional, Huber, Kurt, additional, Janzon, Magnus, additional, Lapostolle, Frédéric, additional, Lassen, Jens Flensted, additional, Licour, Muriel, additional, Merkely, Béla, additional, Salhi, Néjoua, additional, Silvain, Johanne, additional, Storey, Robert F., additional, ten Berg, Jurriën M., additional, Tsatsaris, Anne, additional, Zeymer, Uwe, additional, Vicaut, Eric, additional, Hamm, Christian W., additional, Bougherbal, Rachid, additional, Bouafia, Mohamed Tahar, additional, Nibouche, Djamaleddine, additional, Moklati, Abdelkader, additional, Benalia, Ahmed, additional, Kaid, Omar, additional, Krim, Messaad, additional, Hammett, Christopher, additional, Garrahy, Paul, additional, Jayasinghe, Rohan, additional, Rashford, Stephen, additional, Neunteufl, Thomas, additional, Brussee, Helmut, additional, Alber, Hannes, additional, Weidinger, Franz, additional, Brunner, Michael, additional, Sipoetz, Johann, additional, Prause, Gerhard, additional, Baubin, Michael, additional, Sebald, Dieter, additional, Cantor, Warren, additional, Vijayaraghavan, Ram, additional, Bata, Iqbal, additional, Lavoie, Andrea, additional, Ravkilde, Jan, additional, Jensen, Lisette Okkels, additional, Christensen, Alf Møl, additional, Toftegaard, Marianne, additional, Köhler, Dennis, additional, Montalescot, Gilles, additional, Ducrocq, Gregory, additional, Danchin, Nicolas, additional, Henry, Patrick, additional, Livarek, Bernard, additional, Berthier, Romain, additional, Hovasse, Thomas, additional, Garot, Philippe, additional, Payot, Laurent, additional, Benamer, Hakim, additional, Esteve, Jean Baptiste, additional, Elhadad, Simon, additional, Teiger, Emmanuel, additional, Bonnet, Jean Louis, additional, Paganelli, Franck, additional, Cottin, Yves, additional, Schiele, François, additional, Thuaire, Christophe, additional, Cayla, Guillaume, additional, Coste, Pierre, additional, Ohlmann, Patrick, additional, Cudraz, Eric Bonnefoy, additional, Lantelme, Pierre, additional, Perret, Thibault, additional, Tron, Christophe, additional, De Labriolle, Axel, additional, Aptecar, Edouardo, additional, Beliard, Olivier, additional, Varenne, Olivier, additional, El Mahmoud, Rami, additional, Filippi-Codaccioni, Emmanuelle, additional, Angoulvant, Denis, additional, Peycher, Patrick, additional, Poitrineau, Olivier, additional, Tabone, Xavier, additional, Ecollan, Patrick, additional, Broche, Claire, additional, Lambert, Yves, additional, Briole, Nicolas, additional, Beruben, Arielle, additional, Porcher, Nicolas, additional, Auffray, Jean-Pierre, additional, Freysz, Marc, additional, Depardieu, Franck, additional, Poubel, David, additional, De La Cousaye, Jean-Emmanuel, additional, Bartier, Jean-Claude, additional, Jardel, Benoît, additional, Boulanger, Bertrand, additional, Labourel, Hervé, additional, Soulat, Louis-Christophe, additional, Julie, Véronique, additional, Thicoipe, Michel, additional, Capel, Olivier, additional, Stibbe, Olivier, additional, Carli, Pierre, additional, Tazarourte, Karim, additional, Alcouffe, Fabrice, additional, Aboucaya, David, additional, Aubert, Gaële, additional, Kierzek, Gérald, additional, Cahun-Giraud, Séverine, additional, Hamm, Christian, additional, Dengler, Thomas, additional, Prondzinsky, Roland, additional, Biever, Paul Marc, additional, Schäfer, Andreas, additional, Seyfarth, Melchior, additional, Lemke, Bernd, additional, Werner, Gerald, additional, Nef, Holger, additional, Steiger, Holger, additional, Leschke, Matthias, additional, Münzel, Thomas, additional, Dell Orto, Marco Campo, additional, Loges, Christian, additional, Schinke, Monika, additional, Koberne, Frank, additional, Reiffen, Hans Peter, additional, Tiroch, Klaus, additional, Wierich, Dirk, additional, Kneussel, Michael, additional, Little, Simon, additional, Sauer, Hartmut, additional, Laufenberg-Feldmann, Rita, additional, Ungi, Imre, additional, Horváth, Iván, additional, Édes, István, additional, Mártai, István, additional, Berti, Sergio, additional, Chiarella, Francesco, additional, Calabria, Paolo, additional, Fineschi, Massimo, additional, Galvani, Marcello, additional, Valgimigli, Marco, additional, Moretti, Luciano, additional, Tespili, Maurizio, additional, Mandó, Massimo, additional, Bermano, Francesco, additional, Biagioni, Robusto, additional, Fabbri, Andrea, additional, Ricciardelli, Adelina, additional, Petroni, Maria Romana, additional, Vatteroni, Umberto Roberto, additional, Palumbo, Francesco, additional, Willems, Frank F., additional, Al Mafragi, Amar, additional, Heestermans, Ton A.A.C.M., additional, Van Eck, Martijn J., additional, Heutz, Wim M.J.M., additional, Meppelder, H.H., additional, Jong, Anika Roukema-de, additional, Van de Pas, Harm, additional, Fillat, Ángel Cequier, additional, Tenas, Manel Sabaté, additional, Ferrer, Josepa Mauri, additional, Peñaranda, Antoni Serra, additional, Ferrer, Joan Ángel, additional, Del Blanco, Bruno García, additional, Guardiola, Faustino Miranda, additional, Ruiz Nodar, Juan Miguel, additional, Romo, Andrés Íñiguez, additional, González, Nicolás Vázquez, additional, Nouche, Ramiro Trillo, additional, De La Llera, Luis Díaz, additional, Hernández García, José María, additional, Rivero-Crespo, Fernando, additional, Hernández, Felipe Hernández, additional, Zamorano Gómez, José Luis, additional, Fárega, Xavier Jiménez, additional, Fernández, Gilberto Alonso, additional, Toboso, José Luis, additional, Carrasco, Mercedes, additional, Barreiro, Victoria, additional, Iglesias Vázquez, José Antonio, additional, Montero, María del Mar Ruiz, additional, Ortiz, Fernando Rosell, additional, Escudero, Guillermo Garcia, additional, Ingelmo, Vicente Sánchez-Brunete, additional, García, Antonio Lara, additional, Oldgren, Jonas, additional, Calais, Fredrik, additional, Kastberg, Robert, additional, Bergsten, Per-Adolf, additional, Blomberg, Hans, additional, Thörn, Kristian, additional, Skoog, Gunnar, additional, Zaman, Azfar, additional, Gerber, Robert, additional, Ryding, Alisdair, additional, Spence, Mark, additional, Swanson, Neil, additional, Been, Martin, additional, Grosser, Konrad, additional, Schofield, Peter, additional, Mackin, David, additional, Fell, Paul, additional, Quinn, Tom, additional, Foster, Teresa, additional, McManus, David, additional, and Carson, Andy, additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results